What remains unknown Despite encouraging data, genuine unknowns exist: Effects beyond 6-9 months of continuous use have not been formally studied in animals or humans
Safety and side effect profiles Both BPC-157 and TB-500 demonstrate favorable safety profiles across research applications and practical use
This impairment of DNA synthesis affects the rapidly dividing cells of the bone marrow earlier than other cells, resulting in the production of large, immature, hemoglobin-poor red blood cells (macrocytosis), as well as effects on white blood cells, including abnormal (hypersegmented) neutrophils and reduced overall cell counts (pancytopenia)
Periodic serum B12 and metabolic marker rechecking ensures safety and efficacy
It has been shown to promote gut health, reduce inflammation, and potentially address conditions like inflammatory bowel disease and leaky gut syndrome